QLY Biotech Group (QLY Biotech Group) EV-to-EBIT : -134.86 (As of May. 25, 2024)

QLY Biotech Group EV-to-EBIT Chart

QLY Biotech Group Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23
EV-to-EBIT	Get a 7-Day Free Trial												-	-488.88	-292.13	-215.25	-141.03

Competitive Comparison of QLY Biotech Group's EV-to-EBIT

For the Travel Services subindustry, QLY Biotech Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

QLY Biotech Group's EV-to-EBIT Distribution in the Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, QLY Biotech Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where QLY Biotech Group's EV-to-EBIT falls into.

QLY Biotech Group EV-to-EBIT Calculation

QLY Biotech Group's EV-to-EBIT for today is calculated as:

QLY Biotech Group's current Enterprise Value is $3.91 Mil.
QLY Biotech Group's EBIT for the trailing twelve months (TTM) ended in Feb. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QLY Biotech Group  (OTCPK:LQLY) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

QLY Biotech Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2023 is calculated as:

QLY Biotech Group's Enterprise Value for the quarter that ended in Feb. 2023 was $4.09 Mil.
QLY Biotech Group's EBIT for the trailing twelve months (TTM) ended in Feb. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QLY Biotech Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of QLY Biotech Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

QLY Biotech Group (QLY Biotech Group) Business Description